Evaluation of diagnostic values of photodynamic diagnosis in identifying the dermal and mucosal squamous cell carcinoma

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 4, 2012, Pages 293-298

  Kamrava, Seyed Kamran ^a   Behtaj, Mohadese ^a   Ghavami, Yaser ^a   Shahabi, Shahab ^a   Jalessi, Maryam ^a   Afshar, Elnaz Ehteshami ^a   Maleki, Shayan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Diagnostic values; Pathology; Photodynamic diagnosis; SCC

Indexed keywords

PHOTOSENSITIZING AGENT; RADACHLORIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DESCRIPTIVE RESEARCH; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LASER; MALE; MUCOSAL SQUAMOUS CELL CARCINOMA; PHOTODYNAMIC DIAGNOSIS; PHOTODYNAMICS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 84870331028     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.03.004     Document Type: Article

References (22)

1. Jung G., Metelitsa A., Dover D., Salopek T. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007. Br J Dermatol 2010, 163:146-154. 10.1111/j.1365-2133.2010.09809.
2. Raab C. über die Wirkung fluoreszierender Stoffe auf Infusoria. Z Biol 1900, 39:524-546.
3. Von Tappeiner H., Jesionek A. Therapeutische Versuche mit fluoreszierenden Stoffen. MMW 1903, 50:2042-2044.
4. Jesionek A., von Tappeiner H. Zur Behandlung von Hautcarcinomen mit fluorescierenden Stoffen. Arch Klin Med 1905, 82:72-76.
5. Moan J., Peng Q. An outline of the hundred-year history of PDT. Anticancer Res 2003, 23:3591-3600.
6. Taub A.F. Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol 2004, 3:S8-S25.
7. Christensen E., Warloe T., Kroon S., et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010, 24(5):505-512. 10.1111/j.1468-3083.2009.03430.
8. Stenquist B., Ericson M.B., Strandeberg C., et al. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery. Br J Dermatol 2006, 154(2):305-309.
9. Ganly I., Kaye S.B. Recurrent squamous cell carcinoma of the head and neck: overview of current therapy and future prospects. Ann Oncol. 2000, 11:11-16.
10. Ollstein R.N. Skin lesions in the elderly: precancer and cancer. Care Manag J 2004, 5(2):107-111. Summer.
11. Decker J. Keeping watch for skin cancers on the head and neck. ENT Today J 2006, September.
12. Chaturvedi P., Majumder S.K., Krishna H., Muttaqi S., Gupta P.K. Fluorescence spectroscopy for noninvasive early diagnosis of oral mucosal malignant and potentially malignant lesions. J cancer Res Ther 2010, 6:497-502.
13. Angell-Petersen E., Sorensen R., Warloe T., et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006, 126(2):265-267.
14. Ceilley R.I., del Rosso J.Q. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006, 45(5):489-498.
15. ®: Skin cancer PDT phase II clinical trials. Photodiagnosis Photodyn Ther 2010, 7:258-267. Epub 2010 Aug 14.
16. ® sensitizer for photodynamic therapy. Photochem Photobiol Sci 2009, 8:405-413.
17. S. Douillard, D. Oliver, T. Patrice, In vitro evaluation of Radachlorin® sensitizer for photodynamic therapy Department Laser, Neurochirurgie, CHU Nantes, 44093 Nantes, France.
18. Proceedings of SPIE, Volume 5863, " Therapeutic Laser Applications and Laser-Tissue Interactions" , II" , Editors: Hubert van den Bergh, Alfred Vogel, pp. 186-198, 2005.
19. Rhodes L.E., de Rie M., Enstrom Y., et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004, 140:17-23.
20. Calzavara-Pinton P.G., Venturini M., Sala R., et al. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008, 159:137-144. Epub 2008 Jul 1.
21. Fai D., Arpaia N., Romano I., Vestita M., Cassano N., Vena G.A. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. G Ital Dermatol Venereol 2009, 144:281-285.
22. Farhadi M., Kamrava S.K., Behzadi A.H., et al. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma. J Drugs Dermatol 2010, 9(February (2)):122-126.